nodes	percent_of_prediction	percent_of_DWPC	metapath
Dinoprost Tromethamine—SLCO3A1—Methotrexate—psoriasis	0.256	0.45	CbGbCtD
Dinoprost Tromethamine—SLC22A11—Methotrexate—psoriasis	0.0844	0.148	CbGbCtD
Dinoprost Tromethamine—SLC22A7—Methotrexate—psoriasis	0.0804	0.141	CbGbCtD
Dinoprost Tromethamine—SLC22A6—Cyclosporine—psoriasis	0.0647	0.114	CbGbCtD
Dinoprost Tromethamine—SLC22A8—Methotrexate—psoriasis	0.0491	0.0863	CbGbCtD
Dinoprost Tromethamine—SLC22A6—Methotrexate—psoriasis	0.0342	0.0601	CbGbCtD
Dinoprost Tromethamine—GALR3—Peptide ligand-binding receptors—CCL20—psoriasis	0.00118	0.0185	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—GPCR ligand binding—HCAR2—psoriasis	0.00116	0.0182	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Integrated Pancreatic Cancer Pathway—PTTG1—psoriasis	0.00111	0.0174	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Class A/1 (Rhodopsin-like receptors)—HCAR2—psoriasis	0.00107	0.0167	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—G alpha (i) signalling events—CCL20—psoriasis	0.000999	0.0156	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Thromboxane A2 receptor signaling—ICAM1—psoriasis	0.000931	0.0146	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—GPCR ligand binding—HCAR2—psoriasis	0.000903	0.0141	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Hemostasis—SERPINB8—psoriasis	0.00088	0.0138	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—GPCR ligand binding—HCAR2—psoriasis	0.000814	0.0128	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—HCAR2—psoriasis	0.0008	0.0125	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Class A/1 (Rhodopsin-like receptors)—CCL20—psoriasis	0.000794	0.0124	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Class A/1 (Rhodopsin-like receptors)—HCAR2—psoriasis	0.000783	0.0123	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—HCAR2—psoriasis	0.000783	0.0123	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Aryl Hydrocarbon Receptor—NFKB1—psoriasis	0.000757	0.0119	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—psoriasis	0.000754	0.0118	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—G alpha (i) signalling events—CCL20—psoriasis	0.000699	0.0109	CbGpPWpGaD
Dinoprost Tromethamine—SLCO2A1—SLC-mediated transmembrane transport—CP—psoriasis	0.000688	0.0108	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Aryl Hydrocarbon Receptor—VEGFA—psoriasis	0.000687	0.0108	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A7—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—psoriasis	0.000684	0.0107	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—GPCR downstream signaling—HCAR2—psoriasis	0.000658	0.0103	CbGpPWpGaD
Dinoprost Tromethamine—SLCO3A1—SLC-mediated transmembrane transport—CP—psoriasis	0.000652	0.0102	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Class A/1 (Rhodopsin-like receptors)—CCL20—psoriasis	0.000616	0.00964	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Thromboxane A2 receptor signaling—ICAM1—psoriasis	0.000615	0.00963	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—GPCR ligand binding—HCAR2—psoriasis	0.000609	0.00954	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—GPCR ligand binding—CCL20—psoriasis	0.000605	0.00947	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling by GPCR—HCAR2—psoriasis	0.000598	0.00936	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—GPCR ligand binding—HCAR2—psoriasis	0.000596	0.00934	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—GPCR ligand binding—HCAR2—psoriasis	0.000596	0.00934	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Aryl Hydrocarbon Receptor—TNF—psoriasis	0.000589	0.00922	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—psoriasis	0.000575	0.00901	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Class A/1 (Rhodopsin-like receptors)—CCL20—psoriasis	0.000556	0.0087	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—GPCR downstream signaling—HCAR2—psoriasis	0.00051	0.00799	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—psoriasis	0.00048	0.00752	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—GPCR ligand binding—CCL20—psoriasis	0.000469	0.00734	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Platelet homeostasis—NOS2—psoriasis	0.000468	0.00733	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling by GPCR—HCAR2—psoriasis	0.000463	0.00726	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—GPCR downstream signaling—HCAR2—psoriasis	0.00046	0.00721	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	0.000452	0.00708	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—GPCR ligand binding—CCL20—psoriasis	0.000423	0.00662	CbGpPWpGaD
Dinoprost Tromethamine—Malaise—Hydrocortisone—psoriasis	0.000419	0.00114	CcSEcCtD
Dinoprost Tromethamine—PTGER3—Signaling by GPCR—HCAR2—psoriasis	0.000418	0.00655	CbGpPWpGaD
Dinoprost Tromethamine—Loss of consciousness—Prednisolone—psoriasis	0.000418	0.00114	CcSEcCtD
Dinoprost Tromethamine—Abdominal pain—Mycophenolic acid—psoriasis	0.000417	0.00113	CcSEcCtD
Dinoprost Tromethamine—Body temperature increased—Mycophenolic acid—psoriasis	0.000417	0.00113	CcSEcCtD
Dinoprost Tromethamine—Syncope—Hydrocortisone—psoriasis	0.000416	0.00113	CcSEcCtD
Dinoprost Tromethamine—Dizziness—Hydroxyurea—psoriasis	0.000416	0.00113	CcSEcCtD
Dinoprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—CCL20—psoriasis	0.000415	0.00651	CbGpPWpGaD
Dinoprost Tromethamine—Angiopathy—Dexamethasone—psoriasis	0.000413	0.00113	CcSEcCtD
Dinoprost Tromethamine—Angiopathy—Betamethasone—psoriasis	0.000413	0.00113	CcSEcCtD
Dinoprost Tromethamine—Infection—Mycophenolate mofetil—psoriasis	0.000413	0.00112	CcSEcCtD
Dinoprost Tromethamine—Hyperhidrosis—Cyclosporine—psoriasis	0.000412	0.00112	CcSEcCtD
Dinoprost Tromethamine—Convulsion—Prednisolone—psoriasis	0.000412	0.00112	CcSEcCtD
Dinoprost Tromethamine—Hypertension—Prednisolone—psoriasis	0.00041	0.00112	CcSEcCtD
Dinoprost Tromethamine—Shock—Mycophenolate mofetil—psoriasis	0.000409	0.00111	CcSEcCtD
Dinoprost Tromethamine—Loss of consciousness—Hydrocortisone—psoriasis	0.000408	0.00111	CcSEcCtD
Dinoprost Tromethamine—PTGIR—Class A/1 (Rhodopsin-like receptors)—CCL20—psoriasis	0.000407	0.00637	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—CCL20—psoriasis	0.000407	0.00637	CbGpPWpGaD
Dinoprost Tromethamine—Tachycardia—Mycophenolate mofetil—psoriasis	0.000406	0.0011	CcSEcCtD
Dinoprost Tromethamine—Ill-defined disorder—Triamcinolone—psoriasis	0.000406	0.0011	CcSEcCtD
Dinoprost Tromethamine—Bradycardia—Prednisone—psoriasis	0.000404	0.0011	CcSEcCtD
Dinoprost Tromethamine—Convulsion—Hydrocortisone—psoriasis	0.000402	0.00109	CcSEcCtD
Dinoprost Tromethamine—Hyperhidrosis—Mycophenolate mofetil—psoriasis	0.000402	0.00109	CcSEcCtD
Dinoprost Tromethamine—Hypertension—Hydrocortisone—psoriasis	0.000401	0.00109	CcSEcCtD
Dinoprost Tromethamine—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—psoriasis	0.0004	0.00627	CbGpPWpGaD
Dinoprost Tromethamine—Vomiting—Hydroxyurea—psoriasis	0.0004	0.00109	CcSEcCtD
Dinoprost Tromethamine—Discomfort—Prednisolone—psoriasis	0.0004	0.00109	CcSEcCtD
Dinoprost Tromethamine—Rash—Hydroxyurea—psoriasis	0.000397	0.00108	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Hydroxyurea—psoriasis	0.000396	0.00108	CcSEcCtD
Dinoprost Tromethamine—Malaise—Triamcinolone—psoriasis	0.000394	0.00107	CcSEcCtD
Dinoprost Tromethamine—Headache—Hydroxyurea—psoriasis	0.000394	0.00107	CcSEcCtD
Dinoprost Tromethamine—Syncope—Triamcinolone—psoriasis	0.000392	0.00107	CcSEcCtD
Dinoprost Tromethamine—Discomfort—Hydrocortisone—psoriasis	0.00039	0.00106	CcSEcCtD
Dinoprost Tromethamine—Hypotension—Mycophenolate mofetil—psoriasis	0.000389	0.00106	CcSEcCtD
Dinoprost Tromethamine—Dysuria—Methotrexate—psoriasis	0.000387	0.00105	CcSEcCtD
Dinoprost Tromethamine—TBXA2R—Hemostasis—ITGAL—psoriasis	0.000387	0.00606	CbGpPWpGaD
Dinoprost Tromethamine—Loss of consciousness—Triamcinolone—psoriasis	0.000384	0.00105	CcSEcCtD
Dinoprost Tromethamine—Paraesthesia—Cyclosporine—psoriasis	0.000383	0.00104	CcSEcCtD
Dinoprost Tromethamine—HPGDS—Metabolism—NDUFA5—psoriasis	0.000382	0.00598	CbGpPWpGaD
Dinoprost Tromethamine—Shock—Prednisolone—psoriasis	0.000382	0.00104	CcSEcCtD
Dinoprost Tromethamine—Cough—Triamcinolone—psoriasis	0.000381	0.00104	CcSEcCtD
Dinoprost Tromethamine—Dyspnoea—Cyclosporine—psoriasis	0.00038	0.00103	CcSEcCtD
Dinoprost Tromethamine—HPGDS—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	0.00038	0.00595	CbGpPWpGaD
Dinoprost Tromethamine—Somnolence—Cyclosporine—psoriasis	0.000379	0.00103	CcSEcCtD
Dinoprost Tromethamine—Convulsion—Triamcinolone—psoriasis	0.000379	0.00103	CcSEcCtD
Dinoprost Tromethamine—Tachycardia—Prednisolone—psoriasis	0.000379	0.00103	CcSEcCtD
Dinoprost Tromethamine—Asthenia—Mycophenolic acid—psoriasis	0.000378	0.00103	CcSEcCtD
Dinoprost Tromethamine—Hypertension—Triamcinolone—psoriasis	0.000377	0.00103	CcSEcCtD
Dinoprost Tromethamine—Infection—Hydrocortisone—psoriasis	0.000376	0.00102	CcSEcCtD
Dinoprost Tromethamine—Hyperhidrosis—Prednisolone—psoriasis	0.000375	0.00102	CcSEcCtD
Dinoprost Tromethamine—Nausea—Hydroxyurea—psoriasis	0.000374	0.00102	CcSEcCtD
Dinoprost Tromethamine—Paraesthesia—Mycophenolate mofetil—psoriasis	0.000373	0.00102	CcSEcCtD
Dinoprost Tromethamine—Pruritus—Mycophenolic acid—psoriasis	0.000373	0.00101	CcSEcCtD
Dinoprost Tromethamine—Shock—Hydrocortisone—psoriasis	0.000373	0.00101	CcSEcCtD
Dinoprost Tromethamine—Dyspnoea—Mycophenolate mofetil—psoriasis	0.000371	0.00101	CcSEcCtD
Dinoprost Tromethamine—Tachycardia—Hydrocortisone—psoriasis	0.00037	0.00101	CcSEcCtD
Dinoprost Tromethamine—Somnolence—Mycophenolate mofetil—psoriasis	0.00037	0.00101	CcSEcCtD
Dinoprost Tromethamine—Drowsiness—Methotrexate—psoriasis	0.000369	0.00101	CcSEcCtD
Dinoprost Tromethamine—Ill-defined disorder—Betamethasone—psoriasis	0.000368	0.001	CcSEcCtD
Dinoprost Tromethamine—Ill-defined disorder—Dexamethasone—psoriasis	0.000368	0.001	CcSEcCtD
Dinoprost Tromethamine—Discomfort—Triamcinolone—psoriasis	0.000368	0.001	CcSEcCtD
Dinoprost Tromethamine—Hyperhidrosis—Hydrocortisone—psoriasis	0.000366	0.000997	CcSEcCtD
Dinoprost Tromethamine—Pain—Cyclosporine—psoriasis	0.000364	0.000992	CcSEcCtD
Dinoprost Tromethamine—Diarrhoea—Mycophenolic acid—psoriasis	0.00036	0.000982	CcSEcCtD
Dinoprost Tromethamine—Angiopathy—Prednisone—psoriasis	0.00036	0.00098	CcSEcCtD
Dinoprost Tromethamine—Immune system disorder—Prednisone—psoriasis	0.000358	0.000976	CcSEcCtD
Dinoprost Tromethamine—Malaise—Dexamethasone—psoriasis	0.000358	0.000974	CcSEcCtD
Dinoprost Tromethamine—Malaise—Betamethasone—psoriasis	0.000358	0.000974	CcSEcCtD
Dinoprost Tromethamine—HPGDS—Metabolism of lipids and lipoproteins—CARM1—psoriasis	0.000356	0.00557	CbGpPWpGaD
Dinoprost Tromethamine—Syncope—Betamethasone—psoriasis	0.000356	0.000968	CcSEcCtD
Dinoprost Tromethamine—Syncope—Dexamethasone—psoriasis	0.000356	0.000968	CcSEcCtD
Dinoprost Tromethamine—Pain—Mycophenolate mofetil—psoriasis	0.000356	0.000968	CcSEcCtD
Dinoprost Tromethamine—Infection—Triamcinolone—psoriasis	0.000354	0.000965	CcSEcCtD
Dinoprost Tromethamine—Sweating—Methotrexate—psoriasis	0.000354	0.000964	CcSEcCtD
Dinoprost Tromethamine—Hypotension—Hydrocortisone—psoriasis	0.000354	0.000964	CcSEcCtD
Dinoprost Tromethamine—GALR3—Signaling Pathways—HCAR2—psoriasis	0.000353	0.00553	CbGpPWpGaD
Dinoprost Tromethamine—Haematuria—Methotrexate—psoriasis	0.000352	0.000959	CcSEcCtD
Dinoprost Tromethamine—Feeling abnormal—Cyclosporine—psoriasis	0.000351	0.000956	CcSEcCtD
Dinoprost Tromethamine—Shock—Triamcinolone—psoriasis	0.000351	0.000955	CcSEcCtD
Dinoprost Tromethamine—SLCO2A1—Transmembrane transport of small molecules—CP—psoriasis	0.00035	0.00548	CbGpPWpGaD
Dinoprost Tromethamine—Gastrointestinal pain—Cyclosporine—psoriasis	0.000349	0.000949	CcSEcCtD
Dinoprost Tromethamine—Loss of consciousness—Betamethasone—psoriasis	0.000349	0.000949	CcSEcCtD
Dinoprost Tromethamine—Loss of consciousness—Dexamethasone—psoriasis	0.000349	0.000949	CcSEcCtD
Dinoprost Tromethamine—Dizziness—Mycophenolic acid—psoriasis	0.000348	0.000949	CcSEcCtD
Dinoprost Tromethamine—Epistaxis—Methotrexate—psoriasis	0.000348	0.000948	CcSEcCtD
Dinoprost Tromethamine—Paraesthesia—Prednisolone—psoriasis	0.000348	0.000948	CcSEcCtD
Dinoprost Tromethamine—Tachycardia—Triamcinolone—psoriasis	0.000348	0.000948	CcSEcCtD
Dinoprost Tromethamine—Hyperhidrosis—Triamcinolone—psoriasis	0.000345	0.000939	CcSEcCtD
Dinoprost Tromethamine—PTGFR—GPCR downstream signaling—HCAR2—psoriasis	0.000344	0.00539	CbGpPWpGaD
Dinoprost Tromethamine—Convulsion—Dexamethasone—psoriasis	0.000344	0.000935	CcSEcCtD
Dinoprost Tromethamine—Convulsion—Betamethasone—psoriasis	0.000344	0.000935	CcSEcCtD
Dinoprost Tromethamine—SLC22A11—SLC-mediated transmembrane transport—CP—psoriasis	0.000343	0.00537	CbGpPWpGaD
Dinoprost Tromethamine—Feeling abnormal—Mycophenolate mofetil—psoriasis	0.000343	0.000933	CcSEcCtD
Dinoprost Tromethamine—Hypertension—Dexamethasone—psoriasis	0.000342	0.000932	CcSEcCtD
Dinoprost Tromethamine—Hypertension—Betamethasone—psoriasis	0.000342	0.000932	CcSEcCtD
Dinoprost Tromethamine—GALR3—GPCR downstream signaling—CCL20—psoriasis	0.000342	0.00535	CbGpPWpGaD
Dinoprost Tromethamine—Paraesthesia—Hydrocortisone—psoriasis	0.00034	0.000926	CcSEcCtD
Dinoprost Tromethamine—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	0.00034	0.000926	CcSEcCtD
Dinoprost Tromethamine—Body temperature increased—Cyclosporine—psoriasis	0.000337	0.000917	CcSEcCtD
Dinoprost Tromethamine—Abdominal pain—Cyclosporine—psoriasis	0.000337	0.000917	CcSEcCtD
Dinoprost Tromethamine—PTGIR—GPCR downstream signaling—HCAR2—psoriasis	0.000337	0.00528	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—GPCR downstream signaling—HCAR2—psoriasis	0.000337	0.00528	CbGpPWpGaD
Dinoprost Tromethamine—Vomiting—Mycophenolic acid—psoriasis	0.000335	0.000912	CcSEcCtD
Dinoprost Tromethamine—SLCO2A1—Transmembrane transport of small molecules—CARM1—psoriasis	0.000334	0.00522	CbGpPWpGaD
Dinoprost Tromethamine—Discomfort—Betamethasone—psoriasis	0.000334	0.000908	CcSEcCtD
Dinoprost Tromethamine—Discomfort—Dexamethasone—psoriasis	0.000334	0.000908	CcSEcCtD
Dinoprost Tromethamine—Rash—Mycophenolic acid—psoriasis	0.000332	0.000905	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Mycophenolic acid—psoriasis	0.000332	0.000904	CcSEcCtD
Dinoprost Tromethamine—Pain—Prednisolone—psoriasis	0.000332	0.000903	CcSEcCtD
Dinoprost Tromethamine—SLCO3A1—Transmembrane transport of small molecules—CP—psoriasis	0.000332	0.00519	CbGpPWpGaD
Dinoprost Tromethamine—Headache—Mycophenolic acid—psoriasis	0.00033	0.000899	CcSEcCtD
Dinoprost Tromethamine—Abdominal pain—Mycophenolate mofetil—psoriasis	0.000329	0.000895	CcSEcCtD
Dinoprost Tromethamine—Body temperature increased—Mycophenolate mofetil—psoriasis	0.000329	0.000895	CcSEcCtD
Dinoprost Tromethamine—HPGDS—Metabolism—CYP2S1—psoriasis	0.000325	0.00508	CbGpPWpGaD
Dinoprost Tromethamine—Pain—Hydrocortisone—psoriasis	0.000324	0.000882	CcSEcCtD
Dinoprost Tromethamine—Infection—Betamethasone—psoriasis	0.000322	0.000875	CcSEcCtD
Dinoprost Tromethamine—Infection—Dexamethasone—psoriasis	0.000322	0.000875	CcSEcCtD
Dinoprost Tromethamine—Ill-defined disorder—Prednisone—psoriasis	0.00032	0.000872	CcSEcCtD
Dinoprost Tromethamine—Paraesthesia—Triamcinolone—psoriasis	0.00032	0.000872	CcSEcCtD
Dinoprost Tromethamine—GALR3—Peptide ligand-binding receptors—CXCL8—psoriasis	0.00032	0.00501	CbGpPWpGaD
Dinoprost Tromethamine—Feeling abnormal—Prednisolone—psoriasis	0.00032	0.00087	CcSEcCtD
Dinoprost Tromethamine—Shock—Betamethasone—psoriasis	0.000318	0.000867	CcSEcCtD
Dinoprost Tromethamine—Shock—Dexamethasone—psoriasis	0.000318	0.000867	CcSEcCtD
Dinoprost Tromethamine—Dyspnoea—Triamcinolone—psoriasis	0.000318	0.000866	CcSEcCtD
Dinoprost Tromethamine—Agitation—Prednisone—psoriasis	0.000317	0.000864	CcSEcCtD
Dinoprost Tromethamine—PTGFR—GPCR ligand binding—CCL20—psoriasis	0.000316	0.00495	CbGpPWpGaD
Dinoprost Tromethamine—SLCO3A1—Transmembrane transport of small molecules—CARM1—psoriasis	0.000316	0.00495	CbGpPWpGaD
Dinoprost Tromethamine—Tachycardia—Betamethasone—psoriasis	0.000316	0.00086	CcSEcCtD
Dinoprost Tromethamine—Tachycardia—Dexamethasone—psoriasis	0.000316	0.00086	CcSEcCtD
Dinoprost Tromethamine—Hypersensitivity—Cyclosporine—psoriasis	0.000314	0.000855	CcSEcCtD
Dinoprost Tromethamine—Nausea—Mycophenolic acid—psoriasis	0.000313	0.000852	CcSEcCtD
Dinoprost Tromethamine—Hyperhidrosis—Dexamethasone—psoriasis	0.000313	0.000852	CcSEcCtD
Dinoprost Tromethamine—Hyperhidrosis—Betamethasone—psoriasis	0.000313	0.000852	CcSEcCtD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—HCAR2—psoriasis	0.000313	0.00489	CbGpPWpGaD
Dinoprost Tromethamine—Feeling abnormal—Hydrocortisone—psoriasis	0.000312	0.00085	CcSEcCtD
Dinoprost Tromethamine—Malaise—Prednisone—psoriasis	0.000311	0.000848	CcSEcCtD
Dinoprost Tromethamine—SLC22A7—SLC-mediated transmembrane transport—CP—psoriasis	0.000311	0.00487	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling by GPCR—CCL20—psoriasis	0.00031	0.00486	CbGpPWpGaD
Dinoprost Tromethamine—Gastrointestinal pain—Hydrocortisone—psoriasis	0.00031	0.000843	CcSEcCtD
Dinoprost Tromethamine—Syncope—Prednisone—psoriasis	0.00031	0.000843	CcSEcCtD
Dinoprost Tromethamine—PTGER1—GPCR ligand binding—CCL20—psoriasis	0.00031	0.00485	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—GPCR ligand binding—CCL20—psoriasis	0.00031	0.00485	CbGpPWpGaD
Dinoprost Tromethamine—Hypersensitivity—Mycophenolate mofetil—psoriasis	0.000306	0.000834	CcSEcCtD
Dinoprost Tromethamine—GALR3—Signaling Pathways—TAGAP—psoriasis	0.000306	0.00479	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—HCAR2—psoriasis	0.000306	0.00479	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—HCAR2—psoriasis	0.000306	0.00479	CbGpPWpGaD
Dinoprost Tromethamine—Asthenia—Cyclosporine—psoriasis	0.000306	0.000833	CcSEcCtD
Dinoprost Tromethamine—Pain—Triamcinolone—psoriasis	0.000305	0.00083	CcSEcCtD
Dinoprost Tromethamine—Loss of consciousness—Prednisone—psoriasis	0.000304	0.000826	CcSEcCtD
Dinoprost Tromethamine—Hypotension—Betamethasone—psoriasis	0.000302	0.000823	CcSEcCtD
Dinoprost Tromethamine—Hypotension—Dexamethasone—psoriasis	0.000302	0.000823	CcSEcCtD
Dinoprost Tromethamine—Pruritus—Cyclosporine—psoriasis	0.000302	0.000821	CcSEcCtD
Dinoprost Tromethamine—SLC22A7—Fluoropyrimidine Activity—TP53—psoriasis	0.000301	0.00472	CbGpPWpGaD
Dinoprost Tromethamine—Angiopathy—Methotrexate—psoriasis	0.000301	0.000819	CcSEcCtD
Dinoprost Tromethamine—Immune system disorder—Methotrexate—psoriasis	0.000299	0.000815	CcSEcCtD
Dinoprost Tromethamine—Abdominal pain—Hydrocortisone—psoriasis	0.000299	0.000815	CcSEcCtD
Dinoprost Tromethamine—Body temperature increased—Hydrocortisone—psoriasis	0.000299	0.000815	CcSEcCtD
Dinoprost Tromethamine—Convulsion—Prednisone—psoriasis	0.000299	0.000815	CcSEcCtD
Dinoprost Tromethamine—Asthenia—Mycophenolate mofetil—psoriasis	0.000298	0.000812	CcSEcCtD
Dinoprost Tromethamine—Hypertension—Prednisone—psoriasis	0.000298	0.000812	CcSEcCtD
Dinoprost Tromethamine—Chills—Methotrexate—psoriasis	0.000297	0.00081	CcSEcCtD
Dinoprost Tromethamine—Pruritus—Mycophenolate mofetil—psoriasis	0.000294	0.000801	CcSEcCtD
Dinoprost Tromethamine—Feeling abnormal—Triamcinolone—psoriasis	0.000294	0.0008	CcSEcCtD
Dinoprost Tromethamine—Diarrhoea—Cyclosporine—psoriasis	0.000292	0.000794	CcSEcCtD
Dinoprost Tromethamine—Paraesthesia—Betamethasone—psoriasis	0.000291	0.000791	CcSEcCtD
Dinoprost Tromethamine—Paraesthesia—Dexamethasone—psoriasis	0.000291	0.000791	CcSEcCtD
Dinoprost Tromethamine—Discomfort—Prednisone—psoriasis	0.00029	0.000791	CcSEcCtD
Dinoprost Tromethamine—Hypersensitivity—Prednisolone—psoriasis	0.000286	0.000778	CcSEcCtD
Dinoprost Tromethamine—Diarrhoea—Mycophenolate mofetil—psoriasis	0.000284	0.000775	CcSEcCtD
Dinoprost Tromethamine—Body temperature increased—Triamcinolone—psoriasis	0.000282	0.000768	CcSEcCtD
Dinoprost Tromethamine—Dizziness—Cyclosporine—psoriasis	0.000282	0.000767	CcSEcCtD
Dinoprost Tromethamine—Infection—Prednisone—psoriasis	0.00028	0.000762	CcSEcCtD
Dinoprost Tromethamine—Back pain—Methotrexate—psoriasis	0.000279	0.00076	CcSEcCtD
Dinoprost Tromethamine—Hypersensitivity—Hydrocortisone—psoriasis	0.000279	0.00076	CcSEcCtD
Dinoprost Tromethamine—Shock—Prednisone—psoriasis	0.000277	0.000755	CcSEcCtD
Dinoprost Tromethamine—Pain—Betamethasone—psoriasis	0.000277	0.000754	CcSEcCtD
Dinoprost Tromethamine—Pain—Dexamethasone—psoriasis	0.000277	0.000754	CcSEcCtD
Dinoprost Tromethamine—Tachycardia—Prednisone—psoriasis	0.000275	0.000749	CcSEcCtD
Dinoprost Tromethamine—Dizziness—Mycophenolate mofetil—psoriasis	0.000275	0.000749	CcSEcCtD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—HCAR2—psoriasis	0.000274	0.00429	CbGpPWpGaD
Dinoprost Tromethamine—Hyperhidrosis—Prednisone—psoriasis	0.000272	0.000742	CcSEcCtD
Dinoprost Tromethamine—Asthenia—Hydrocortisone—psoriasis	0.000272	0.00074	CcSEcCtD
Dinoprost Tromethamine—Vomiting—Cyclosporine—psoriasis	0.000271	0.000738	CcSEcCtD
Dinoprost Tromethamine—GALR3—G alpha (i) signalling events—CXCL8—psoriasis	0.00027	0.00422	CbGpPWpGaD
Dinoprost Tromethamine—Rash—Cyclosporine—psoriasis	0.000269	0.000732	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Cyclosporine—psoriasis	0.000269	0.000731	CcSEcCtD
Dinoprost Tromethamine—Pruritus—Hydrocortisone—psoriasis	0.000268	0.00073	CcSEcCtD
Dinoprost Tromethamine—Ill-defined disorder—Methotrexate—psoriasis	0.000268	0.000729	CcSEcCtD
Dinoprost Tromethamine—Headache—Cyclosporine—psoriasis	0.000267	0.000727	CcSEcCtD
Dinoprost Tromethamine—Feeling abnormal—Dexamethasone—psoriasis	0.000267	0.000726	CcSEcCtD
Dinoprost Tromethamine—Feeling abnormal—Betamethasone—psoriasis	0.000267	0.000726	CcSEcCtD
Dinoprost Tromethamine—TBXA2R—GPCR downstream signaling—CCL20—psoriasis	0.000265	0.00415	CbGpPWpGaD
Dinoprost Tromethamine—Gastrointestinal pain—Dexamethasone—psoriasis	0.000265	0.000721	CcSEcCtD
Dinoprost Tromethamine—Gastrointestinal pain—Betamethasone—psoriasis	0.000265	0.000721	CcSEcCtD
Dinoprost Tromethamine—Vomiting—Mycophenolate mofetil—psoriasis	0.000264	0.00072	CcSEcCtD
Dinoprost Tromethamine—Hypersensitivity—Triamcinolone—psoriasis	0.000263	0.000716	CcSEcCtD
Dinoprost Tromethamine—Rash—Mycophenolate mofetil—psoriasis	0.000262	0.000714	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Mycophenolate mofetil—psoriasis	0.000262	0.000713	CcSEcCtD
Dinoprost Tromethamine—SLC22A8—SLC-mediated transmembrane transport—CP—psoriasis	0.000261	0.00409	CbGpPWpGaD
Dinoprost Tromethamine—Headache—Mycophenolate mofetil—psoriasis	0.00026	0.000709	CcSEcCtD
Dinoprost Tromethamine—Malaise—Methotrexate—psoriasis	0.00026	0.000709	CcSEcCtD
Dinoprost Tromethamine—Diarrhoea—Hydrocortisone—psoriasis	0.000259	0.000706	CcSEcCtD
Dinoprost Tromethamine—TBXA2R—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—psoriasis	0.000258	0.00404	CbGpPWpGaD
Dinoprost Tromethamine—Dizziness—Prednisolone—psoriasis	0.000256	0.000698	CcSEcCtD
Dinoprost Tromethamine—Asthenia—Triamcinolone—psoriasis	0.000256	0.000697	CcSEcCtD
Dinoprost Tromethamine—Body temperature increased—Dexamethasone—psoriasis	0.000256	0.000697	CcSEcCtD
Dinoprost Tromethamine—Body temperature increased—Betamethasone—psoriasis	0.000256	0.000697	CcSEcCtD
Dinoprost Tromethamine—Abdominal pain—Dexamethasone—psoriasis	0.000256	0.000697	CcSEcCtD
Dinoprost Tromethamine—Abdominal pain—Betamethasone—psoriasis	0.000256	0.000697	CcSEcCtD
Dinoprost Tromethamine—PTGIR—Hemostasis—ITGAL—psoriasis	0.000256	0.004	CbGpPWpGaD
Dinoprost Tromethamine—Nausea—Cyclosporine—psoriasis	0.000253	0.000689	CcSEcCtD
Dinoprost Tromethamine—Paraesthesia—Prednisone—psoriasis	0.000253	0.000689	CcSEcCtD
Dinoprost Tromethamine—Pruritus—Triamcinolone—psoriasis	0.000252	0.000687	CcSEcCtD
Dinoprost Tromethamine—Cough—Methotrexate—psoriasis	0.000252	0.000686	CcSEcCtD
Dinoprost Tromethamine—HPGDS—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	0.000252	0.00394	CbGpPWpGaD
Dinoprost Tromethamine—Dizziness—Hydrocortisone—psoriasis	0.00025	0.000682	CcSEcCtD
Dinoprost Tromethamine—Convulsion—Methotrexate—psoriasis	0.00025	0.000681	CcSEcCtD
Dinoprost Tromethamine—Nausea—Mycophenolate mofetil—psoriasis	0.000247	0.000672	CcSEcCtD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—HCAR2—psoriasis	0.000247	0.00387	CbGpPWpGaD
Dinoprost Tromethamine—Chest pain—Methotrexate—psoriasis	0.000246	0.000669	CcSEcCtD
Dinoprost Tromethamine—Rash—Prednisolone—psoriasis	0.000245	0.000666	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Prednisolone—psoriasis	0.000244	0.000665	CcSEcCtD
Dinoprost Tromethamine—Headache—Prednisolone—psoriasis	0.000243	0.000662	CcSEcCtD
Dinoprost Tromethamine—Discomfort—Methotrexate—psoriasis	0.000243	0.000661	CcSEcCtD
Dinoprost Tromethamine—HPGDS—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	0.000242	0.00379	CbGpPWpGaD
Dinoprost Tromethamine—Vomiting—Hydrocortisone—psoriasis	0.000241	0.000656	CcSEcCtD
Dinoprost Tromethamine—TBXA2R—Signaling by GPCR—CCL20—psoriasis	0.000241	0.00377	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—GPCR downstream signaling—CCL20—psoriasis	0.000239	0.00374	CbGpPWpGaD
Dinoprost Tromethamine—Rash—Hydrocortisone—psoriasis	0.000239	0.00065	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Hydrocortisone—psoriasis	0.000239	0.00065	CcSEcCtD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—TAGAP—psoriasis	0.000237	0.00372	CbGpPWpGaD
Dinoprost Tromethamine—Headache—Hydrocortisone—psoriasis	0.000237	0.000646	CcSEcCtD
Dinoprost Tromethamine—Dizziness—Triamcinolone—psoriasis	0.000236	0.000642	CcSEcCtD
Dinoprost Tromethamine—Infection—Methotrexate—psoriasis	0.000234	0.000637	CcSEcCtD
Dinoprost Tromethamine—Feeling abnormal—Prednisone—psoriasis	0.000232	0.000632	CcSEcCtD
Dinoprost Tromethamine—Asthenia—Betamethasone—psoriasis	0.000232	0.000632	CcSEcCtD
Dinoprost Tromethamine—Asthenia—Dexamethasone—psoriasis	0.000232	0.000632	CcSEcCtD
Dinoprost Tromethamine—Gastrointestinal pain—Prednisone—psoriasis	0.00023	0.000628	CcSEcCtD
Dinoprost Tromethamine—Nausea—Prednisolone—psoriasis	0.00023	0.000627	CcSEcCtD
Dinoprost Tromethamine—Pruritus—Betamethasone—psoriasis	0.000229	0.000623	CcSEcCtD
Dinoprost Tromethamine—Pruritus—Dexamethasone—psoriasis	0.000229	0.000623	CcSEcCtD
Dinoprost Tromethamine—Hyperhidrosis—Methotrexate—psoriasis	0.000228	0.00062	CcSEcCtD
Dinoprost Tromethamine—Vomiting—Triamcinolone—psoriasis	0.000227	0.000617	CcSEcCtD
Dinoprost Tromethamine—Nausea—Hydrocortisone—psoriasis	0.000225	0.000613	CcSEcCtD
Dinoprost Tromethamine—Rash—Triamcinolone—psoriasis	0.000225	0.000612	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Triamcinolone—psoriasis	0.000225	0.000612	CcSEcCtD
Dinoprost Tromethamine—Headache—Triamcinolone—psoriasis	0.000223	0.000608	CcSEcCtD
Dinoprost Tromethamine—Body temperature increased—Prednisone—psoriasis	0.000223	0.000607	CcSEcCtD
Dinoprost Tromethamine—Abdominal pain—Prednisone—psoriasis	0.000223	0.000607	CcSEcCtD
Dinoprost Tromethamine—Diarrhoea—Betamethasone—psoriasis	0.000221	0.000603	CcSEcCtD
Dinoprost Tromethamine—Diarrhoea—Dexamethasone—psoriasis	0.000221	0.000603	CcSEcCtD
Dinoprost Tromethamine—Hypotension—Methotrexate—psoriasis	0.00022	0.000599	CcSEcCtD
Dinoprost Tromethamine—HPGDS—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	0.00022	0.00344	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A6—SLC-mediated transmembrane transport—CP—psoriasis	0.000218	0.00342	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling by GPCR—CCL20—psoriasis	0.000217	0.0034	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	0.000215	0.00336	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—TAGAP—psoriasis	0.000214	0.00335	CbGpPWpGaD
Dinoprost Tromethamine—Dizziness—Dexamethasone—psoriasis	0.000214	0.000583	CcSEcCtD
Dinoprost Tromethamine—Dizziness—Betamethasone—psoriasis	0.000214	0.000583	CcSEcCtD
Dinoprost Tromethamine—Nausea—Triamcinolone—psoriasis	0.000212	0.000577	CcSEcCtD
Dinoprost Tromethamine—Paraesthesia—Methotrexate—psoriasis	0.000212	0.000576	CcSEcCtD
Dinoprost Tromethamine—Dyspnoea—Methotrexate—psoriasis	0.00021	0.000572	CcSEcCtD
Dinoprost Tromethamine—Somnolence—Methotrexate—psoriasis	0.000209	0.00057	CcSEcCtD
Dinoprost Tromethamine—Hypersensitivity—Prednisone—psoriasis	0.000208	0.000565	CcSEcCtD
Dinoprost Tromethamine—Vomiting—Betamethasone—psoriasis	0.000206	0.00056	CcSEcCtD
Dinoprost Tromethamine—Vomiting—Dexamethasone—psoriasis	0.000206	0.00056	CcSEcCtD
Dinoprost Tromethamine—Rash—Dexamethasone—psoriasis	0.000204	0.000556	CcSEcCtD
Dinoprost Tromethamine—Rash—Betamethasone—psoriasis	0.000204	0.000556	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Betamethasone—psoriasis	0.000204	0.000555	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Dexamethasone—psoriasis	0.000204	0.000555	CcSEcCtD
Dinoprost Tromethamine—Headache—Betamethasone—psoriasis	0.000203	0.000552	CcSEcCtD
Dinoprost Tromethamine—Headache—Dexamethasone—psoriasis	0.000203	0.000552	CcSEcCtD
Dinoprost Tromethamine—Asthenia—Prednisone—psoriasis	0.000202	0.000551	CcSEcCtD
Dinoprost Tromethamine—Pain—Methotrexate—psoriasis	0.000201	0.000548	CcSEcCtD
Dinoprost Tromethamine—Pruritus—Prednisone—psoriasis	0.000199	0.000543	CcSEcCtD
Dinoprost Tromethamine—Feeling abnormal—Methotrexate—psoriasis	0.000194	0.000529	CcSEcCtD
Dinoprost Tromethamine—Diarrhoea—Prednisone—psoriasis	0.000193	0.000525	CcSEcCtD
Dinoprost Tromethamine—Gastrointestinal pain—Methotrexate—psoriasis	0.000193	0.000524	CcSEcCtD
Dinoprost Tromethamine—Nausea—Betamethasone—psoriasis	0.000192	0.000523	CcSEcCtD
Dinoprost Tromethamine—Nausea—Dexamethasone—psoriasis	0.000192	0.000523	CcSEcCtD
Dinoprost Tromethamine—PTGER3—G alpha (i) signalling events—CXCL8—psoriasis	0.000189	0.00295	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	0.000188	0.00295	CbGpPWpGaD
Dinoprost Tromethamine—Dizziness—Prednisone—psoriasis	0.000186	0.000507	CcSEcCtD
Dinoprost Tromethamine—Body temperature increased—Methotrexate—psoriasis	0.000186	0.000507	CcSEcCtD
Dinoprost Tromethamine—Abdominal pain—Methotrexate—psoriasis	0.000186	0.000507	CcSEcCtD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—HCAR2—psoriasis	0.000185	0.00289	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—CCL20—psoriasis	0.000183	0.00287	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—SLC-mediated transmembrane transport—CP—psoriasis	0.000182	0.00285	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—HCAR2—psoriasis	0.000181	0.00283	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—HCAR2—psoriasis	0.000181	0.00283	CbGpPWpGaD
Dinoprost Tromethamine—Vomiting—Prednisone—psoriasis	0.000179	0.000488	CcSEcCtD
Dinoprost Tromethamine—PTGFR—GPCR downstream signaling—CCL20—psoriasis	0.000179	0.0028	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Platelet activation, signaling and aggregation—VEGFA—psoriasis	0.000178	0.00279	CbGpPWpGaD
Dinoprost Tromethamine—Rash—Prednisone—psoriasis	0.000178	0.000484	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Prednisone—psoriasis	0.000178	0.000483	CcSEcCtD
Dinoprost Tromethamine—Headache—Prednisone—psoriasis	0.000177	0.000481	CcSEcCtD
Dinoprost Tromethamine—PTGIR—GPCR downstream signaling—CCL20—psoriasis	0.000175	0.00274	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—GPCR downstream signaling—CCL20—psoriasis	0.000175	0.00274	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A11—Transmembrane transport of small molecules—CP—psoriasis	0.000174	0.00273	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—psoriasis	0.000174	0.00272	CbGpPWpGaD
Dinoprost Tromethamine—Hypersensitivity—Methotrexate—psoriasis	0.000174	0.000473	CcSEcCtD
Dinoprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—psoriasis	0.00017	0.00267	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Metabolism of lipids and lipoproteins—APOE—psoriasis	0.00017	0.00266	CbGpPWpGaD
Dinoprost Tromethamine—Asthenia—Methotrexate—psoriasis	0.000169	0.00046	CcSEcCtD
Dinoprost Tromethamine—Nausea—Prednisone—psoriasis	0.000167	0.000456	CcSEcCtD
Dinoprost Tromethamine—Pruritus—Methotrexate—psoriasis	0.000167	0.000454	CcSEcCtD
Dinoprost Tromethamine—TBXA2R—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	0.000166	0.0026	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	0.000166	0.0026	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A11—Transmembrane transport of small molecules—CARM1—psoriasis	0.000166	0.0026	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—GPCR ligand binding—CXCL8—psoriasis	0.000163	0.00256	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—CCL20—psoriasis	0.000162	0.00254	CbGpPWpGaD
Dinoprost Tromethamine—Diarrhoea—Methotrexate—psoriasis	0.000161	0.000439	CcSEcCtD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—TAGAP—psoriasis	0.00016	0.00251	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—CCL20—psoriasis	0.000159	0.00249	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—CCL20—psoriasis	0.000159	0.00249	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Hemostasis—NOS2—psoriasis	0.000159	0.00249	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Metabolism—CARM1—psoriasis	0.000159	0.00248	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A7—Transmembrane transport of small molecules—CP—psoriasis	0.000158	0.00247	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—TAGAP—psoriasis	0.000157	0.00245	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—TAGAP—psoriasis	0.000157	0.00245	CbGpPWpGaD
Dinoprost Tromethamine—Dizziness—Methotrexate—psoriasis	0.000156	0.000424	CcSEcCtD
Dinoprost Tromethamine—SLC22A7—Transmembrane transport of small molecules—CARM1—psoriasis	0.000151	0.00236	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	0.00015	0.00235	CbGpPWpGaD
Dinoprost Tromethamine—Vomiting—Methotrexate—psoriasis	0.00015	0.000408	CcSEcCtD
Dinoprost Tromethamine—Rash—Methotrexate—psoriasis	0.000149	0.000404	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Methotrexate—psoriasis	0.000148	0.000404	CcSEcCtD
Dinoprost Tromethamine—HPGDS—Metabolism of lipids and lipoproteins—PPARG—psoriasis	0.000148	0.00232	CbGpPWpGaD
Dinoprost Tromethamine—Headache—Methotrexate—psoriasis	0.000148	0.000402	CcSEcCtD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—CCL20—psoriasis	0.000142	0.00223	CbGpPWpGaD
Dinoprost Tromethamine—Nausea—Methotrexate—psoriasis	0.00014	0.000381	CcSEcCtD
Dinoprost Tromethamine—SLC22A8—Transmembrane transport of small molecules—CP—psoriasis	0.000133	0.00208	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—CCL20—psoriasis	0.000128	0.00201	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A8—Transmembrane transport of small molecules—CARM1—psoriasis	0.000127	0.00198	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—GPCR ligand binding—CXCL8—psoriasis	0.000127	0.00198	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—psoriasis	0.000126	0.00198	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—GPCR ligand binding—CXCL8—psoriasis	0.000114	0.00179	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	0.000112	0.00176	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A6—Transmembrane transport of small molecules—CP—psoriasis	0.000111	0.00174	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	0.00011	0.00172	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	0.00011	0.00172	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A6—Transmembrane transport of small molecules—CARM1—psoriasis	0.000106	0.00166	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Hemostasis—NOS2—psoriasis	0.000105	0.00164	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—SOCS1—psoriasis	0.000101	0.00158	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—NDUFA5—psoriasis	9.94e-05	0.00156	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Metabolism—CAT—psoriasis	9.75e-05	0.00153	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling by GPCR—TYK2—psoriasis	9.63e-05	0.00151	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—CCL20—psoriasis	9.59e-05	0.0015	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—CCL20—psoriasis	9.39e-05	0.00147	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—CCL20—psoriasis	9.39e-05	0.00147	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Transmembrane transport of small molecules—CP—psoriasis	9.24e-05	0.00145	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—GPCR downstream signaling—CXCL8—psoriasis	9.23e-05	0.00145	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Hemostasis—VEGFA—psoriasis	9.2e-05	0.00144	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Transmembrane transport of small molecules—CARM1—psoriasis	8.82e-05	0.00138	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—GPCR ligand binding—CXCL8—psoriasis	8.54e-05	0.00134	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—psoriasis	8.51e-05	0.00133	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—CYP2S1—psoriasis	8.46e-05	0.00132	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling by GPCR—CXCL8—psoriasis	8.38e-05	0.00131	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—GPCR ligand binding—CXCL8—psoriasis	8.36e-05	0.00131	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—GPCR ligand binding—CXCL8—psoriasis	8.36e-05	0.00131	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—psoriasis	8.33e-05	0.0013	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—SOCS1—psoriasis	7.83e-05	0.00123	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Metabolism—APOE—psoriasis	7.58e-05	0.00119	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling by GPCR—TYK2—psoriasis	7.47e-05	0.00117	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—APOE—psoriasis	7.45e-05	0.00117	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—LEP—psoriasis	7.45e-05	0.00117	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—GPCR downstream signaling—CXCL8—psoriasis	7.16e-05	0.00112	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—SOCS1—psoriasis	7.06e-05	0.00111	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Hemostasis—TP53—psoriasis	6.95e-05	0.00109	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—NFKBIA—psoriasis	6.94e-05	0.00109	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling by GPCR—TYK2—psoriasis	6.73e-05	0.00105	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Metabolism—PPARG—psoriasis	6.6e-05	0.00103	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling by GPCR—CXCL8—psoriasis	6.5e-05	0.00102	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—GPCR downstream signaling—CXCL8—psoriasis	6.46e-05	0.00101	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Hemostasis—VEGFA—psoriasis	6.07e-05	0.000951	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling by GPCR—CXCL8—psoriasis	5.86e-05	0.000918	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—LEP—psoriasis	5.78e-05	0.000905	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—APOE—psoriasis	5.78e-05	0.000905	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—TYK2—psoriasis	5.69e-05	0.000891	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—NFKBIA—psoriasis	5.38e-05	0.000843	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—SOCS1—psoriasis	5.28e-05	0.000827	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—LEP—psoriasis	5.21e-05	0.000816	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—APOE—psoriasis	5.21e-05	0.000816	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—SOCS1—psoriasis	5.17e-05	0.000809	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—SOCS1—psoriasis	5.17e-05	0.000809	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—TYK2—psoriasis	5.04e-05	0.000788	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—CXCL8—psoriasis	4.95e-05	0.000775	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—TYK2—psoriasis	4.93e-05	0.000772	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—TYK2—psoriasis	4.93e-05	0.000772	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—NFKBIA—psoriasis	4.86e-05	0.00076	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—GPCR downstream signaling—CXCL8—psoriasis	4.83e-05	0.000756	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—GPCR downstream signaling—CXCL8—psoriasis	4.73e-05	0.00074	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—GPCR downstream signaling—CXCL8—psoriasis	4.73e-05	0.00074	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling by GPCR—IL6—psoriasis	4.71e-05	0.000737	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—JUN—psoriasis	4.6e-05	0.000721	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Hemostasis—TP53—psoriasis	4.59e-05	0.000719	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—NFKB1—psoriasis	4.43e-05	0.000694	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—TYK2—psoriasis	4.41e-05	0.000691	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—CXCL8—psoriasis	4.38e-05	0.000686	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—CXCL8—psoriasis	4.29e-05	0.000672	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—CXCL8—psoriasis	4.29e-05	0.000672	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—CARM1—psoriasis	4.13e-05	0.000647	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—VEGFA—psoriasis	4.02e-05	0.00063	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—STAT3—psoriasis	3.98e-05	0.000624	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—TYK2—psoriasis	3.98e-05	0.000623	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—LEP—psoriasis	3.9e-05	0.00061	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—APOE—psoriasis	3.9e-05	0.00061	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—CXCL8—psoriasis	3.84e-05	0.000601	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—APOE—psoriasis	3.81e-05	0.000597	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—LEP—psoriasis	3.81e-05	0.000597	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—LEP—psoriasis	3.81e-05	0.000597	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—APOE—psoriasis	3.81e-05	0.000597	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling by GPCR—IL6—psoriasis	3.65e-05	0.000572	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—NFKBIA—psoriasis	3.63e-05	0.000569	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—JUN—psoriasis	3.57e-05	0.000559	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—NFKBIA—psoriasis	3.55e-05	0.000557	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—NFKBIA—psoriasis	3.55e-05	0.000557	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—CXCL8—psoriasis	3.46e-05	0.000542	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—NFKB1—psoriasis	3.44e-05	0.000538	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling by GPCR—IL6—psoriasis	3.29e-05	0.000516	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—JUN—psoriasis	3.22e-05	0.000504	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—VEGFA—psoriasis	3.12e-05	0.000488	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—NFKB1—psoriasis	3.1e-05	0.000485	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—STAT3—psoriasis	3.09e-05	0.000484	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—TP53—psoriasis	3.04e-05	0.000476	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—TYK2—psoriasis	2.97e-05	0.000466	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—TYK2—psoriasis	2.91e-05	0.000456	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—TYK2—psoriasis	2.91e-05	0.000456	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—VEGFA—psoriasis	2.81e-05	0.00044	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—STAT3—psoriasis	2.79e-05	0.000436	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—IL6—psoriasis	2.78e-05	0.000436	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—CXCL8—psoriasis	2.59e-05	0.000406	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—CAT—psoriasis	2.54e-05	0.000398	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—CXCL8—psoriasis	2.53e-05	0.000397	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—CXCL8—psoriasis	2.53e-05	0.000397	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—IL6—psoriasis	2.46e-05	0.000386	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—IL6—psoriasis	2.41e-05	0.000377	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—IL6—psoriasis	2.41e-05	0.000377	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—JUN—psoriasis	2.41e-05	0.000377	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—JUN—psoriasis	2.36e-05	0.000369	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—JUN—psoriasis	2.36e-05	0.000369	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—TP53—psoriasis	2.36e-05	0.000369	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—NFKB1—psoriasis	2.32e-05	0.000363	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—NFKB1—psoriasis	2.27e-05	0.000355	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—NFKB1—psoriasis	2.27e-05	0.000355	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—IL6—psoriasis	2.16e-05	0.000338	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—TP53—psoriasis	2.13e-05	0.000333	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—VEGFA—psoriasis	2.1e-05	0.000329	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—STAT3—psoriasis	2.08e-05	0.000326	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—VEGFA—psoriasis	2.06e-05	0.000322	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—VEGFA—psoriasis	2.06e-05	0.000322	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—STAT3—psoriasis	2.04e-05	0.000319	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—STAT3—psoriasis	2.04e-05	0.000319	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—APOE—psoriasis	1.97e-05	0.000309	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—IL6—psoriasis	1.95e-05	0.000305	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—PPARG—psoriasis	1.72e-05	0.000269	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—TP53—psoriasis	1.59e-05	0.000249	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—TP53—psoriasis	1.56e-05	0.000244	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—TP53—psoriasis	1.56e-05	0.000244	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—IL6—psoriasis	1.45e-05	0.000228	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—IL6—psoriasis	1.42e-05	0.000223	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—IL6—psoriasis	1.42e-05	0.000223	CbGpPWpGaD
